HomepageEarnings Events Newsdesk 4 hours ago Fidelity National Financial, Inc (FNF) Q4 2025 Earnings Results Fidelity National Financial, Inc (NYSE: FNF) Q4 2025 Earnings Release Johnson & Johnson (JNJ) RYBREVANT FASPRO™ (amivantamab and hyaluronidase-lpuj) plus immunotherapy shows strong clinical benefit with 56 percent overall response rate in first-line recurrent or metastatic head and neck cancer » « Boyd Gaming Corp (BYD) Dividend Update Newsdesk: